Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan: Milestone Pharmaceuticals, Inc. (MIST)

Milestone Pharmaceuticals (MIST) is automating patient telemetry collection via cloud IT solutions to accelerate clinical trials. The quarterly EPS growth profile helps assess the efficiency of these processes, where -5.80 characterizes this valuation parameter. The company is implementing the Etripamil nasal spray for self-administered tachycardia termination, expanding its presence in the over-the-counter emergency cardiology segment through innovative self-administration methods.

Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Milestone Pharmaceuticals Inc. (MIST): kanggo periode 04.07.2022 - 13.11.2026

Rincian analitis perusahaan Milestone Pharmaceuticals

- nilai pasar lan prakiraan target analis:

Bagan rega Milestone Pharmaceuticals Inc.|MIST - Target median analis

- indikator kapitalisasi bursa perusahaan:

Biji pasar Milestone Pharma|MIST - Total Nilai Bisnis

- indikator kapitalisasi buku:

Aset Bersih saben Siji Saham Milestone Pharmaceuticals|MIST - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku milestonepharma.com|MIST - Total Aset Bisnis

- indikator total utang lan likuiditas perusahaan:

Total Utang marang Modal Milestone Pharmaceuticals|MIST - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Milestone Pharmaceuticals|MIST - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Milestone Pharma|MIST - Kewajiban jangka dawa|Utang jangka cendhak perusahaan Milestone Pharmaceuticals|Rasio cepet milestonepharma.com

- rincian bathi lan kelipatan pasar:

MIST - Bathi resik|Bathi sing dikarepake Milestone Pharmaceuticals|MIST - Nilai perusahaan marang bathi resik|Rega marang bathi mangsa ngarep Milestone Pharma|MIST - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Milestone Pharma|MIST - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Milestone Pharmaceuticals|MIST - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan milestonepharma.com|MIST - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Milestone Pharmaceuticals

Ringkesan analitik perusahaan:Milestone Pharmaceuticals

A portfolio analyst utilizes this tool to filter for fundamental leaders within the biopharmaceutical sector. The metric measures the percentage change in net earnings per share between the current and previous quarters. For Milestone Pharmaceuticals (MIST), this growth reflects the efficiency of its expansion into the emergency arrhythmia care segment. GURU.Markets investors should correlate the quarterly EPS growth vector with the issuer's debt obligations. Positive momentum confirms the commercial success of the innovative drugs.

Perusahaan pesaing